medigraphic.com

2015, Number 4

<< Back Next >>

Rev Fac Med UNAM 2015; 58 (4)

Smile enhancement with botulinum toxin in a patient with facial palsy

Afrashtehfar CDM, Afrashtehfar KI

Language: Spanish
References: 15
Page: 34-38
PDF size: 206.79 Kb.


ABSTRACT

By altering muscle function, facial palsy causes functional, psychological, emotional, aesthetic and social changes. There are several etiologies and multiple treatments to treat paralyzed side. However, patients with longstanding facial palsy, patients in whom surgical treatment has generated minimal benefits or patients who are not candidates for surgical treatments, the use of botulinum toxin is an adequate alternative to treat affected side when there are sequelae as sinkynesis, hypertony or hemifacial spasm. In the unaffected side is also used to cause static and dynamic aesthetic and functional symmetry.
We present a male patient with right idiopathic facial palsy treated with selective contralateral chemodenervation with botulinum toxin. This treatment resulted in the patient’s favorable evolution towards functionality and normalization of dynamic facial symmetry.


REFERENCES

  1. De Maio M, Rzany B. Botulinum Toxin in Aesthetic Medicine. Germany. Springer, 2007.

  2. Sadiq SA, Khwaja S, Saeed SR. Botulinum toxin to improve lower facial symmetry in facial nerve palsy. Eye. 2012;26:1431-6.

  3. Shafshak TS. The treatment of facial palsy from the point of view of physical and rehabilitation medicine. Eura Medicophys. 2006;42:41-7.

  4. Navarrete-Álvaro ML, Junyent J, Torrent L. Botulinum toxin and facial palsy. Our experience. Acta Otorrinolaringol Esp. 2010;61(4):277-81.

  5. Spataro E, Desai SC, Branham G. The Role of Botulinum Toxin Injections in the Treatment of Facial Nerve Palsy. Austin J Otolaryngol. 2014;1(4):01-3.

  6. Gilden DH, Tyler KL. Bell´s Palsy – Is Glucocorticoid Treatment Enough? N Engl J Med. 2007;357(16):1653-5.

  7. Tiemstra JD, Khatkhate N. Bell´s Palsy: Diagnosis and Management. Am Fam Physician. 2007;76:997-1002.

  8. Chan JYK, Byrne PJ. Management of Facial Paralysis in the 21st Century. Facial Past Surg. 2011;27:246-57.

  9. Finsterer J. Management of peripheral facial nerve palsy. Eur Arch Otorhinolaryngol. 2008;256:743-52

  10. De Maio M, Ferreira-Bento R. Botulinum Toxin in Facial Palsy: An Effective Treatment for Contralateral Hyperkinesis. Plast Reconstr Surg. 2007;120:917-27

  11. Cortés-Monroy C, Soza S. Usos prácticos de la toxina botulínica en adultos en medicina física y rehabilitación. Rev Med Clin Condes. 2014;24(2):225-36.

  12. Gómez-Martín C, Fonseca-Valero R, Galán-Fajardo JM. Utilización de la toxina botulínica para mejorar la funcionalidad y la expresión del labio en parálisis facial de larga evolución. Cir Plast Iberolatinoam. 2010;36(2):175-8.

  13. Mehta RP, Hadlock TA. Botulinum Toxin and Quality of Life in Patients with Facial Paralysis. Arch Facial Plast Surg. 2008;10(2):84-7.

  14. Armstrong MWJ, Mountain RE, Murray JAM. Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol. 1996;21:15-20.

  15. de Maio M. Therapeutic uses of botulinum toin: from facial palsy to autonomic disorders. Expert Opin Biol Ther. 2008;8(6):791-8.




2020     |     www.medigraphic.com